37 results
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
31 Jan 24
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
9:00am
405 under the Securities Act, and “General Disclosure Package” means the Base Prospectus, as amended or supplemented immediately prior … , the General Disclosure Package or the Prospectus, and all other references of like import, shall be deemed to mean and include all such financial
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
12 Oct 23
Astria Therapeutics Announces Pricing of $64 Million Underwritten Offering
5:04pm
the meaning set forth in Rule 405 under the Securities Act, and “General Disclosure Package” means the Base Prospectus, as amended or supplemented … , any preliminary prospectus, the Base Prospectus, the General Disclosure Package or the Prospectus, and all other references of like import, shall
8-K
EX-1.1
4v2r 4mj3
15 Dec 22
Astria Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
5:18pm
8-K
EX-1.1
6skwm3opm
30 Jan 20
Catabasis Pharmaceuticals Announces Pricing of $23 Million Underwritten Public Offering
4:03pm